Johnson & Johnson

JNJ: NYSE
45Total

Lowest reading is at 18 out of 100. All scores are out of 100.

About The Company

CEO

Mr. Joaquin Duato

Market Cap

653.61 Billion USD

Sector

Healthcare

Website

https://www.jnj.com

Last Update

26/09/2026, 10:17:02

Description

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Read More

Strongest readings

  • ✔Debt is low at 0.51 times equity
  • ✔Share count has been falling at 2.21% per year

Weakest readings

  • ✘Revenue is growing at 5.17% per year while free cashflow is falling
  • ✘The current price sits above estimated fair value (margin of safety -80.51%)
  • ✘Priced well above the cashflow it produces (value score 18 out of 100)
  • ✘Price-to-earnings of 31.0 is above the market average of 19.6
  • ✘Earnings have fallen this year (-7.22%)

Key Figures

StatusMetricValueReadingMarket avg
✘
Price / earnings (TTM)
31.05x
19.60x
✘
Margin of safety (DCF)
-80.51%
17.95%
✘
Revenue growth (5y average)
5.17%
10.97%
✘
Dividend yield (TTM)
0.00%
1.85%
✔
Share count, per year
-2.21%
0.00%
✘Return on capital employed0.00%
10.00%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Valuation

18 / 100

Priced above the market on most measures.

StatusMetricValueReadingMarket avg
✘
Price / earnings
31.05x
19.60x
✘Free cashflow yield3.40%
4.70%
✔Price / earnings growth0.34x
1.50x
Price / book7.69x
—
✘
Margin of safety
-80.51%
17.95%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Estimated intrinsic value of 52.87 USD is below the current price of 271.22 USD

Desired Margin Of Safety

0%

▼

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Estimated Fair Value: 127 USD ✘

Current Price: 271.2 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.

Growth

50 / 100

Growing faster than the market on most measures.

StatusMetricValueReadingMarket avg
✘
Revenue growth
5.17%
10.97%
✔Earnings growth58.45%
14.48%
✘Cashflow growth-1.43%
12.35%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✔Revenue growth has improved this year (8.06% against a five year average of 5.17%)
  • ✘Earnings growth has slowed this year (-7.22% against a five year average of 58.45%)
  • ✔Free cashflow growth has improved this year
  • ✘Revenue is growing at 5.17% per year while free cashflow is falling at 1.43% per year

Health

52 / 100

Balance sheet covers its obligations.

Measured on Leverage and capital, Funding and liquidity, Earnings quality.

StatusMetricValueReadingThreshold
Altman-Z scoreN/A3.00
✘Piotroski score3.00
5.00
✔Debt / equity0.51x
0.80x
✔Current ratio1.03x
1.00x
Interest coverageN/A2.50x
✔Free cashflow / debt0.48x
0.15x
✔Debt / capital0.34x
1.00x

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Management

    59 / 100

    Returns on capital are at or above the market.

    StatusMetricValueReadingMarket avg
    ✔Return on equity32.87%
    15.00%
    ✘Return on capital employed0.00%
    10.00%
    Return on assets13.46%
    —
    Free cashflow return on capital13.58%
    —
    Return on capital, 5y changeN/A0.00%
    ✔
    Share count, per year
    -2.21%
    0.00%
    ✘Share count, recent0.10%
    0.00%
    ✔Realized buyback return203.90%
    0.00%
    ✘Goodwill erosion / equity13.44%
    2.00%
    Price volatility, 5 year16.73%
    —

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    • ✘Shares were repurchased while the value score was only 18 out of 100
    • ✘Return on equity of 32.87% is driven by debt rather than operations, because return on capital employed is only 0.00%

    Analysts

    not enough data
    StatusMetricValueReadingNeutral
    Analyst opinion scoreN/A50

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Financial History

    Annual figures across the full reporting history we hold.

    Market Peers

    JNJ

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    See 35+ Years Annual Reports

    Other Information

    Company Name

    Johnson & Johnson

    Currency

    USD

    Beta

    0.235

    Vol Avg

    7044396

    Ceo

    Mr. Joaquin Duato

    Cik

    0000200406

    Cusip

    Exchange

    NYSE

    Full Time Employees

    138200

    Industry

    Drug Manufacturers - General

    Sector

    Healthcare

    Ipo Date

    Address

    One Johnson & Johnson Plaza

    City

    New Brunswick

    State

    NJ

    Country

    United States

    Zip

    08933

    Phone

    732 524 0400

    Analysis Last Updated

    26/09/2026, 10:17:02

    Financial data compiled from SEC EDGAR filings and Yahoo Finance.

    Noticed an error with something on our site?

    Data, not advice. Do your own diligence.

    We Use Cookies